Literature DB >> 7888939

ABC of rheumatology. Rheumatoid arthritis--I: Clinical features and diagnosis.

M Akil1, R S Amos.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7888939      PMCID： PMC2548948          DOI： 10.1136/bmj.310.6979.587

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors.

Authors:  Justin E Jones; Jessica L Slack; Pengfei Fang; Xuesen Zhang; Venkataraman Subramanian; Corey P Causey; Scott A Coonrod; Min Guo; Paul R Thompson
Journal:  ACS Chem Biol       Date:  2011-10-21       Impact factor: 5.100

2.  The cost effectiveness of infliximab for severe treatment-resistant rheumatoid arthritis in the UK.

Authors:  Marco Barbieri; John B Wong; Michael Drummond
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 3.  Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.

Authors:  B Bannwarth; F Péhourcq; T Schaeverbeke; J Dehais
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

4.  Association of the Smad3 and NFATc2 gene polymorphisms and their serum levels with susceptibility to rheumatoid arthritis in Polish cohorts.

Authors:  A Paradowska-Gorycka; K Romanowska-Próchnicka; E Haladyj; M Manczak; S Maslinski; M Olesinska
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

5.  Coping with arthritis is experienced as a dynamic balancing process. A qualitative study.

Authors:  Kjersti Grønning; Borghild Lomundal; Hege Svean Koksvik; Aslak Steinsbekk
Journal:  Clin Rheumatol       Date:  2011-09-03       Impact factor: 2.980

6.  Protein arginine deiminase 4: evidence for a reverse protonation mechanism.

Authors:  Bryan Knuckley; Monica Bhatia; Paul R Thompson
Journal:  Biochemistry       Date:  2007-05-12       Impact factor: 3.162

7.  Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors.

Authors:  Bryan Knuckley; Yuan Luo; Paul R Thompson
Journal:  Bioorg Med Chem       Date:  2007-10-13       Impact factor: 3.641

Review 8.  Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis.

Authors:  C P Rains; S Noble; D Faulds
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

9.  Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2.

Authors:  Wei Gao; Catherine Sweeney; Ceara Walsh; Peadar Rooney; Jennifer McCormick; Douglas J Veale; Ursula Fearon
Journal:  Ann Rheum Dis       Date:  2012-11-17       Impact factor: 19.103

10.  Discovery of a new class of inhibitors for the protein arginine deiminase type 4 (PAD4) by structure-based virtual screening.

Authors:  Chian Ying Teo; Steven Shave; Adam Leow Thean Chor; Abu Bakar Salleh; Mohd Basyaruddin Bin Abdul Rahman; Malcolm D Walkinshaw; Bimo A Tejo
Journal:  BMC Bioinformatics       Date:  2012-12-13       Impact factor: 3.169
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.